Shyamli Kumar
About Shyamli Kumar
Shyamli Kumar is a Senior Manager of Partnership and Development Finance at Arcus Biosciences, with extensive experience in financial planning and analysis across various industries. She has held significant roles in companies such as Gilead Sciences, Jane Technologies, and Shipt, and holds an MBA in Finance from Northeastern University.
Current Role at Arcus Biosciences
Shyamli Kumar serves as the Senior Manager of Partnership and Development Finance at Arcus Biosciences. She has been in this role since 2024, contributing to the financial strategies that support the company's partnerships and development initiatives. Her responsibilities include overseeing financial planning and analysis, ensuring that the financial aspects of partnerships align with the company's overall strategic goals.
Previous Experience at Gilead Sciences
Shyamli Kumar worked as a Senior Financial Analyst at Gilead Sciences from 1998 to 1999. During her tenure in Foster City, California, she focused on financial analysis and reporting, contributing to the company's financial health during a pivotal time in its growth. This role provided her with foundational experience in the biotech industry.
Education and Expertise
Shyamli Kumar holds a Master of Business Administration (MBA) with a concentration in Finance from Northeastern University. Her academic background supports her extensive expertise in budgeting and forecasting, which plays a crucial role in strategic business planning across various industries.
Diverse Industry Experience
Shyamli Kumar has extensive experience in financial planning and analysis across multiple sectors, including biotech, e-commerce, software, and insurance. Her ability to adapt financial strategies to different business models has been demonstrated through her roles in both startup environments and established corporations, enhancing operational efficiencies.
Career Progression and Roles
Throughout her career, Shyamli Kumar has held various significant positions. She served as Director of FP&A at Jane Technologies, Inc. from 2022 to 2023, and at Shipt from 2018 to 2022. Her earlier roles include Financial Planning Analyst at Flow Pharma Inc and Senior Financial Analyst positions at InterMune and Aradigm Corporation. This progression showcases her growth and versatility in financial management.